Crusonia Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
1,400
+376
+37% +$384K 0.28% 66
2026
Q1
$942K Buy
1,024
+80
+8% +$81.1K 0.19% 79
2025
Q4
$1.01M Buy
+944
New +$903K 0.22% 75

Other funds holding LLY

Crusonia Wealth Advisors's LLY Position: Q2 2026 in Review

Crusonia Wealth Advisors increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $384K and bringing the position to 1,400 shares worth $1.68M. The position accounts for 0.28% of the portfolio, ranked #66.

Crusonia Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Crusonia Wealth Advisors held 1,400 shares of Eli Lilly worth $1.68M as of Q2 2026.
  • Crusonia Wealth Advisors bought 376 Eli Lilly shares in Q2 2026, an estimated $384K.
  • Eli Lilly made up 0.28% of Crusonia Wealth Advisors's portfolio in Q2 2026, its #66 holding.
  • Crusonia Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Crusonia Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.